(Q36546675)

14 August 2017

1 reference

title

Modulators of P-glycoprotein-associated multidrug resistance (English)

1 reference

14 August 2017

main subject

multiple drug resistance

1 reference

W. T. Beck

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1686715

29 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1686715

29 October 2022

publication date

1 January 1991

1 reference

full work available at URL

14 August 2017

http://link.springer.com/content/pdf/10.1007/978-1-4615-3872-1_7.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Cancer Treatment and Research

29 October 2022

published in

1 reference

14 August 2017

volume

57

1 reference

14 August 2017

page(s)

151-170

1 reference

The biochemistry of P-glycoprotein-mediated multidrug resistance

14 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

Multidrug resistance

3

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

The cell biology of multiple drug resistance

29 October 2022

4

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Multidrug resistance and its circumvention

29 October 2022

6

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

29 October 2022

8

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins

29 October 2022

9

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance

29 October 2022

10

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance

29 October 2022

11

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

12

45

3657

K Bhalla

1985

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Adriamycin resistance in HL60 cells in the absence of detectable P-glycoprotein

29 October 2022

13

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

14

47

1297

MK Danks

1987

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

15

49

4542

WG Harker

1989

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.

29 October 2022

16

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

18

48

5096

BK Sinha

1988

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

19

49

58

AM Deffie

1989

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

20

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Role of glutathione and its associated enzymes in multidrug-resistant human myeloma cells.

29 October 2022

21

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Expression of a multidrug resistance gene in human cancers

29 October 2022

24

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling

29 October 2022

26

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Photoaffinity labeling of P-glycoprotein in multidrug resistant cells with photoactive analogs of colchicine.

29 October 2022

28

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil

29 October 2022

29

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

30

49

5002

K Yusa

1989

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

31

50

1132

X Qian

1990

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

32

32

1195

H Riehm

1972

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

33

40

1077

T Skovsgaard

1980

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

34

41

1967

T Tsuruo

1981

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

35

49

3190

M Kamiwatari

1989

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffinity labeling of P-glycoprotein

29 October 2022

36

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Reversal of multidrug resistance by new dihydropyridines with lower calcium antagonistic activity

29 October 2022

37

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

38

42

4730

T Tsuruo

1982

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Circumvention of adriamycin resistance by dipyridamole analogues: a structure-activity relationship study

29 October 2022

39

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Increase of sensitivity and uptake of vinblastine by reserpine in rat ascites hepatoma.

29 October 2022

43

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

44

33

454

JM Zamora

1988

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

46

34

180

WD Klohs

1989

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cells

29 October 2022

47

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Lysosomotropic agents reverse multiple drug resistance in human cancer cells

29 October 2022

48

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

49

47

2413

N Shiraishi

1987

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

50

46

4453

M Nakagawa

1986

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

53

49

6901

MP Goslan

1989

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

DNA cross-linking and cytotoxicity of the alkylating cyanomorpholino derivative of doxorubicin in multidrug-resistant cells

29 October 2022

54

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo

29 October 2022

55

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro

29 October 2022

56

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line

29 October 2022

57

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance

29 October 2022

58

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

59

35

105

JM Ford

1989

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine

29 October 2022

60

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

61

46

778

WT Beck

1986

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

Cancer Treatment Reports

64

66

121

RT Chlebowski

1982

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

65

49

3178

SB Howell

1989

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Enhancement of cytotoxicity of vindesine and cis-platinum for human lung tumours by the use of verapamil in vitro

29 October 2022

66

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.

29 October 2022

69

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Activity of cyclosporin A and a non-immunosuppressive cyclosporin against multidrug resistant leukemic cell lines

29 October 2022

70

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Reduced cyclosporin accumulation in multidrug-resistant cells.

29 October 2022

71

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

75

36

730

S-I Akiyama

1989

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Azidopine photoaffinity labeling of multidrug resistance-associated glycoproteins

29 October 2022

76

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Cytofluorescence localization of adriamycin in resistant colon cancer cells

29 October 2022

82

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Induction by verapamil of a rapid increase in ATP consumption in multidrug‐resistant tumor cells

29 October 2022

83

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

85

24

485

WT Beck

1983

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Increased cytosolic pH in multidrug-resistant human lung tumor cells: effect of verapamil.

29 October 2022

86

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Membrane potential differences between adriamycin-sensitive and -resistant cells as measured by flow cytometry.

29 October 2022

87

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Correction of altered plasma membrane potentials. A possible mechanism of cyclosporin A and verapamil reversal of pleiotropic drug resistance in neoplasia

29 October 2022

88

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Verapamil hypersensitivity of vincristine resistant Chinese hamster ovary cell lines.

29 October 2022

90

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Action of calcium antagonists on multidrug resistant cells. Specific cytotoxicity independent of increased cancer drug accumulation.

29 October 2022

91

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

The reversal of doxorubicin resistance by verapamil is not due to an effect on calcium channels.

29 October 2022

93

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Interactions between calcium antagonists, calcium fluxes and anthracycline transport

29 October 2022

94

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

95

47

3736

N Yamashita

1987

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Comparison of ion channels in multidrug-resistant and -sensitive human leukemic cells

29 October 2022

96

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure

29 October 2022

99

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Structure and function of voltage-sensitive ion channels

29 October 2022

100

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Potentiation of chemotherapeutic effect of vincristine in vincristine resistant tumor bearing mice by calmodulin inhibitor clomipramine

29 October 2022

101

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Verapamil Restoration of Daunorubicin Responsiveness in Daunorubicin-resistant Ehrlich Ascites Carcinoma

29 October 2022

102

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Occurrence of a multidrug-resistant phenotype in human lung xenografts

29 October 2022

104

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

Cancer Treatment Reports

105

69

795

ABI Benson

1985

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients

29 October 2022

106

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Treatment of children with refractory acute lymphocytic leukemia with vincristine and diltiazem.

29 October 2022

107

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial

29 October 2022

108

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

110

49

1063

MS Cairo

1989

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

29 October 2022

111

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans

29 October 2022

112

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenografts

29 October 2022

114

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

120

47

2962

RM Lyall

1987

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells

29 October 2022

121

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

Inhibition of multidrug-resistant human tumor growth in athymic mice by anti-P-glycoprotein monoclonal antibodies.

29 October 2022

122

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3872-1_7

29 October 2022

Identifiers

0 references

1 reference